CymitQuimica logo

CAS 2070015-26-6

:

SRT3025 Hydrochloride

Description:
SRT3025 Hydrochloride is a chemical compound that belongs to a class of substances known as selective modulators of the retinoic acid receptor-related orphan receptor gamma (RORγt). It is primarily investigated for its potential therapeutic applications in autoimmune diseases and inflammatory conditions due to its ability to modulate immune responses. The compound is characterized by its hydrochloride salt form, which enhances its solubility and stability in aqueous solutions, making it suitable for pharmaceutical formulations. SRT3025 exhibits a specific mechanism of action by selectively inhibiting RORγt, thereby influencing the expression of pro-inflammatory cytokines. Its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, are critical for determining its efficacy and safety profile in clinical settings. As research continues, SRT3025 Hydrochloride may offer insights into novel treatment strategies for conditions such as psoriasis and other immune-mediated disorders. However, detailed studies and clinical trials are necessary to fully understand its therapeutic potential and side effects.
Formula:C31H32ClN5O2S2
Synonyms:
  • SIRTUIN MODULATOR 1;SRT3025 HCL
  • SRT3025 Hydrochloride
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.